| 冠心病患者介入治疗后氯吡格雷不同疗程对血清白介素-18和C-反应蛋白的影响 |
| |
| 引用本文： | 吴宗虎,王淑娟.冠心病患者介入治疗后氯吡格雷不同疗程对血清白介素-18和C-反应蛋白的影响[J].中国基层医药,2011,18(15):2048-2049. |
| |
| 作者姓名： | 吴宗虎 王淑娟 |
| |
| 作者单位： | 淄博市中心医院心血管内科,山东省淄博,255000 |
| |
| 摘 要： | 目的评价冠状动脉介入治疗（PCI）后，氯吡格雷不同疗程对血清白细胞介素-18和C-反应蛋白的影响。方法将68例PCI的冠心病患者随机分为氯吡格雷治疗1个月组（A组）34例、氯吡格雷治疗6个月组（B组）34例，观察治疗前、后血清白细胞介素-18（IL-18）和C-反应蛋白（hs-CRP）浓度。结果治疗后B组IL-18和hs—CRP降低更为显著。与A组差异有统计学意义（P〈0．05）。结论氯毗格雷可在常规治疗基础上显著降低冠心病患者PCI术后炎性因子浓度。
|
| 关 键 词： | 放射性 介入性 氯吡格雷 |
The effects of clopidogrel on inflammatory cytokines in patients with coronary heart disease(CHD) after percutaneous coronary intervention(PCI) |
| |
| WU Zong-hu,WANG Shu-juan.The effects of clopidogrel on inflammatory cytokines in patients with coronary heart disease(CHD) after percutaneous coronary intervention(PCI)[J].Chinese Journal of Primary Medicine and Pharmacy,2011,18(15):2048-2049. |
| |
| Authors: | WU Zong-hu WANG Shu-juan |
| |
| Institution: | . Department of Cardiovascular, The Central Hospital of Zibo ,Zibo , Shandong 255000, China |
| |
| Abstract: | Objective To observe the effects of clopidogrel on inflammatory cytokines in patients with coronary heart disease (CHD) after percutaneous coronary intervention (PCI). Methods 68 cases diagnosed of CHD were randomly divided into clopidogrel 1 month group( group A), clopidogrel 6 months (roup B), every group had 34 cases. Before and after treatment adopt fasting blood respectively and in determination of serum interleukin-18 (IL-18)and C-reactive protein(hs-CRP). Results IL-18 and CRP were reduced more apparently in group B. Compared with group A,there were significant differences (P ＜ 0.05 ). Conclusion Clopidogrel could significandy reduce coronary heart disease patients in which based on conventional treatment postoperative PCI inflammatory reaction, reduce the patients with coronary artery disease postoperative PCI vascular inflammatory reaction. |
| |
| Keywords: | Radioactirity Interventional Clopidogrel |
| 本文献已被 维普 万方数据 等数据库收录！ |
